Global Hip Replacement Market is estimated to be valued at US$ 7.0 billion in 2023 and is expected to exhibit a CAGR of 5.5% during the forecast period (2023-2030).
Global Hip Replacement Market- Cross sectional analysis
As product base segment, consist of Devices dominates from the product base segment. For instance, an article published by National Library for Biotechnology Information (NCBI) explains BHR stands for Biremningham Hip Resurfacing. The Biremningham Hip Resurfacing is a metal on metal hip implant system that was approved by the US FDA in 2006. This approval necessitated a multicenter prospective post-market approval study. The goal is to share the results at 10 year follow-up.
Global Hip Replacement Market- Key Trends
Strategies such as choice of components in hip replacement.
The key market players are engaged in adopting inorganic strategies such as choice of components in hip replacement. For instance, on July 19, 2022 Enovis, U.S-based medical technology company driven by innovation, announced the commercial roll-out of ARVIS, a U.S.FDA-cleared augmented reality visualization and information system that has completed over 200 successful trials in the U.S. ARVIS is the only proprietary hands-free, real-time augmented reality technology specifically designed to support orthopedic surgeons in visualizing precision guidance during hip and knee surgery.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients